Heinz Joachim Buettner

Showing 1-8 of 8 articles

The Experts “Live” Workshop of the EuroCTO Club 2017, Berlin

Bufe A, Di Mario C, Landmesser U, Gessner M, Sianos G, Garbo R, Dini C, Lauer B, Boudou N, Grancini L, Avran A, Lauten A, Mashayekhi K, Hildick-Smith D, Escaned J, Buettner H, Reifart N, Lapp H, Galassi A, Werner G

April 20, 2018 | 10.4244/EIJV13I17A324

Clinical implications of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention for chronic total occlusion: role of antegrade and retrograde crossing techniques

Toma A, Stahli B, Gebhard C, Gick M, Minners J, Mashayekhi K, Avran A, Ferenc M, Buettner H, Neumann F

April 20, 2018 | 10.4244/EIJ-D-17-00338

Coronary interventions

Survival after percutaneous coronary intervention for chronic total occlusion in elderly patients

Toma A, Gebhard C, Gick M, Ademaj F, Stahli B, Mashayekhi K, Ferenc M, Neumann F, Buettner H

June 2, 2017 | 10.4244/EIJ-D-16-00499

Long-term outcomes of routine versus provisional T-stenting for de novo coronary bifurcation lesions: five-year results of the Bifurcations Bad Krozingen I study

Ferenc M, Ayoub M, Buettner H, Gick M, Comberg T, Rothe J, Valina C, Hochholzer W, Neumann F

December 20, 2015 | 10.4244/EIJV11I8A175

4D-cardiac CT and IVUS support stenting of left main compression due to an enlarged pulmonary artery

Heidt T, Buettner H, Loffelhardt N, Minners J, Langer M, Neumann F, Bode C, Pache G

December 20, 2015 | 10.4244/EIJV11I8A185

Comparison of bivalirudin and heparin in patients undergoing rotational atherectomy: a subanalysis of the randomised ROTAXUS trial

Akin I, Khattab A, Buettner H, Toelg R, Geist V, Neumann F, Richardt G, Abdel-Wahab M

August 19, 2014 | 10.4244/EIJV10I4A79

Antiplatelet response to the 150-mg maintenance dose of clopidogrel in patients with insufficient platelet inhibition after clopidogrel loading for elective coronary stent placement

Trenk D, Hochholzer W, Müller B, Stratz C, Valina C, Schmiebusch P, Buettner H, Neumann F

August 20, 2008

Prospective non-randomized multi-center evaluation of the non-polymer based ACHIEVE™ Paclitaxel Eluting Coronary Stent System in treatment of lesions with high risk of revascularization due to restenosis: the DELIVER II study

Grube E, Gershlick A, Bartorelli A, Buellesfeld L, Blanchard D, Macaya C, Buettner H, Lim V, Boone E, Dorange C, Marco J

February 20, 2006

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Coronary Artery Thrombosis in COVID-19

Coronary collaterals, the natural grafts of CTO lesions

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

Guidance Papers

Guidelines, consensus & position papers

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease